Property of Marianne Beninato and George Fulk Not to be used without permission
- Apply concepts of MDC and MCID to the
- Understand the limitations of the
- Discuss the ways that the proper
◦
Pt is a 66 year old male with first time right MCA stroke. Prior to his stroke he was working full time as an architect. He is married with 3 grown children, 2 of whom live near by.
Case Presentations (GF) Limitations, cautionary notes (MB) Future Research (MB) Questions (MB and GF)
Distribution-based methods Diagnostic Test (Anchor) Method
Minimal Clinically Important Difference
Minimal Detectable change
Measures of Change and Their Interpretation
◦
Error, reliability, Standard Error of Measurement
Review of Measurement Properties
Health (ICF)
Marianne Beninato, DPT, PhD MGH Institute of Health Professions George Fulk, PT, PhD Clarkson University
Introduction (MB) Overview of Measurement (MB) ◦ International Classification of Functioning, Disability and
The authors have nothing to disclose
interpretation of change scores can inform patient management and clinical decision making
interpretation of outcome measures in various settings and patient subgroups
interpretation of change scores on outcome measures
Compare and contrast the Minimal Detectable Change (MDC) and Minimal Clinically Important Difference (MCID)
Apply the ICF framework to be able to categorize outcome measures according to the ICF
Define important psychometric properties of outcome measures
You are seeing him in the acute care hospital for his PT initial evaluation.
What will you decide to assess? Essential to evidence-based practice
Which clinical assessment tools will you use? Guides clinical decision making
How will you interpret the scores?
How will you know if your patient is getting Frameworks for assessing health and disease better?
◦ The ICF (WHO, 2001) ◦ “Significantly” better?
Better than what?
◦ ◦ Based on what reference point?
Between groups vs Within Patient change
Replaces ICIDH and Nagi Model Health Condition
A meaningful and practical system that can be used by various consumers for health policy, quality assurance and outcome
Body
evaluation in different cultures
Function Activity Participation
Aims
Structure To provide scientific basis for understanding and
◦ studying health and health-related states, outcomes and determinants
Contextual To establish a common language for describing
Factors ◦ health and health-related states in order to improve communication between different users.
Environmental Personal Factors Factors Health Condition
Body Function Activity Participation Body
Structure Function Activity Participation Structure
Physiologic Execution of task Involvement in Contextual functions or or action life situations
Factors anatomical parts Negative aspect: Negative aspect: of the body Limitation Restrictions Negative aspect:
Environmental Personal Factors Factors Impairment
- Relationships among components are not unidirectional or linear or proportional
Hi Mat ‣
‣ Trunk Control Test
‣ Tinetti POMA
‣ Timed Up and Go
Stroke Rehabilitation Assessment of Movement
Postural Assessment Scale for Stroke Patients ‣
Mobility Scale for Acute Stroke ‣
Motor Activity Log ‣
Jebsen Taylor Arm Function Test ‣
Functional Reach ‣
‣ Wolf Motor Function Test
Functional Independence Measure ‣
Functional Gait Assessment ‣
Functional Ambulatory Categories ‣
Falls Efficacy Scale** ‣
Dynamic Gait Index ‣
Chedoke Hand Arm Inventory ‣
Performance Measure ‣
Block & Box Test Brunnel Balance Test Canadian Occupational
(BEST)
‣ Trunk Impairment Scale
BOLD
10 Meter Walk Test Action Research Arm Test Activity-specific Balance
Adalaide Activities Profile BOLD – not included in StrokEdge
◦ Activity: “How difficult was it to bathe yourself?”
◦ BSF: “How would you rate the strength of your leg affected by your stroke?”
Example: Stroke Impact Scale
Include items from more than one ICF component
Some measures are Hybrid
Frenchay Index ‣
Assessment of Life Habits
Stroke-Specific Quality of Life ‣
Stroke Impact Scale** ‣
SF-36 ‣
30 ‣
Stroke Adapted Sickness Impact Scale
Satisfaction with Life Scale ‣
Living ‣
Impact Scale Modified Rankin Scale Reintegration to Normal
EuroQOL Goal Attainment Scale Modified Fatigue
Confidence Scale** Arm Motor Ability Test Berg Balance Scale Balance Evaluation Systems Test
9 Hole Peg Test
‣
NIH Stroke Scale
Dynomometry
‣
Chedoke-McMaster Stroke Assessment
‣
Fugl-Meyer Sensory Assessment
‣
Fugl-Meyer Assessment of Motor Function
‣
‣
6 Minute Walk Test
‣ DTR’s, Ashworth Scale
Contextual Factors Environmental Factors
Structure Activity Participation Personal Factors
Health Condition Body Function
Environmental Factors
Internal influences on functioning Particular background of individual’s life and living, and comprise features of the individual that are not part of health condition
Physical, social and attitudinal environment in which people live
Personal Factors External influences on functioning
- – Limb Movement
Motricity Index
‣
Nottingham Assessment of Somatosensation
5 times Sit to Stand
VO2 Max
‣
Tardieu Spasticity Scale
‣
Subscales
Stroke Rehabilitation Assessment of Movement
‣
Semmes Weinstein Monofilaments
‣
Rivermead Motor Assessment
‣
Rivermead Assessment of Somatosensory Performance
‣
Rate of Perceived Exertion
‣
- – Mobility Subscale
Orpington Prognostic Scale
‣
- – not included in StrokEdge
◦ Participation: “How much of the time have you been limited in your social activities?”
(Powell and Myers, J Gerontol A Biol Med Sci 1995;
ABC scale
If possible, measure in various domains of ICF
50:28-34) If possible, include measures of personal (Hellstrom and
Falls Efficacy Scale for Stroke factors Lindmark, Clin Rehabil 1999;13:509-17)
This is not always possible or appropriate
Root questions are not about how well or how Condition Health often the activities are performed but how the person feels about doing them Structure Function Activity Participation Body
“How confident are you that you Contextual Factors could…without losing your balance Environmental Factors Factors Personal
Decide what you will be using OM for
◦ Measuring change
Responsiveness
◦ Prediction ◦ Aspect of validity
Are reference psychometrics available?
◦ Small but relevant change
Reliability
◦
Meaningful
◦
Validity
◦
Avoid floor or ceiling effect Group Comparisons
(≥20 % floor or ceiling
effect)
t -tests, ANOVA ◦
Match with
◦ Limits of interpretability health condition (diagnosis)
◦ practice setting
◦ patient subgroup (i.e. stroke severity etc)
◦ stage of recovery
◦ Sources of Error Examples
Why do we take
Normal variability in
measurements? patient performance related to factors such as
◦ Descriptive
Patient Variability fatigue Differentiation
◦ Disease state is more or
Detect change
◦
less stable
Familiarity, expertise
Patient’s cognitive state
with the instrument Rater Variability
Practiced, standardized
technique
Scoring not clearly
Measurement Instrument defined Adapted from Beninato and Portney, 2011JNPT;35: 75-81 Instrument not stable
Differentiating among patients
Random
◦ Will people with more impairment consistently ◦ Scores taken at different time
have lower scores and vice versa? in a truly unchanging person Interclass correlation coefficient (ICC)
◦
will be bell shaped i.e. normal
◦ Unitless measure
distribution
◦ Scored 0 to 1
Systematic
◦ Higher score is better ◦ Scores will be skewed to
greater than or less than the mean http://en.wikipedia.org/wiki/File:Intraclass_correlation_coefficient_graph.png
Consistency of measured values from a truly
2
2 SEM = + SD T2 )/2 x √(SD T1 √1 – ICC
unchanged patient
Mean SD SD Pooled SD ◦ Standard Error of Measurement (SEM)
ICC 2 2 - ICC SEM BBS T1 T2 + SDT2 )/2 √1 √(SDT1
◦ SEM =
1
s √ – r
XX Flansbjer
s is pooled SD of 2 sets of stable scores
PM R 52.0 .88
4.3
3.8 4.05 .3464
1.40
r is reliability coefficient (ICC)
XX 2012;4:165-170
SEM quantifies random error taking into
Hiengkaew
account stability at baseline and test re-test
Arch Phys Med 46.2 .95 7.64 7.87 7.76 .2236
1.73
reliability Rehabil
2012;93:1201-
In same units as outcome measure 1208
SEM assumptions:
◦ A truly stable group of individuals
The means between T1 and T2 should not be
substantially different
◦ Normal distribution of the difference in scores
between T1 and T2
Interpreting reliability studies
◦ The sample studied should resemble your patient ◦ Your actual error could vary depending on your
reliability Beninato M, Portney LG, JNPT, 2011;35:75-81
Initial Exam Follow-up Berg 45 Berg 49 Improvement?? 1 st Berg 44
Initial Exam Follow-up Berg 45 Berg 49 Improvement?? 1 st Berg 42
ERROR ERROR
ERROR ERROR
2 nd Berg 49
◦ For MDC usually 90%
MDC = SD
diff
x z Or
MDC = SEM x √2 x z
◦ SEM x √2 = SD diff
◦
z Indicates level of confidence
(z=1.65) or 95% (z=2.0) confidence
measurement period
◦ Nomenclature: MDC 90 z scores
Interpreting MDC
◦ Based on change in unchanged people ◦ If our patient exceeds the MDC
90
value, we can be 90% certain that this change represents real change and not noise or error
3 rd Berg 46
◦ Patients’ true values do not change from over
3 rd Berg 50
MDC
1 st Berg 48
2 nd Berg 45
3 rd Berg 48
1 st Berg 47
2 nd Berg 49
3 rd Berg 52
Thanks to P. Levangie and D. Gross for image idea
Normal distribution of difference scores reflecting only random error
Smallest amount of change that can be considered above measurement error
Or the smallest amount of change that is REAL change
Quantifies the variability of responses in truly unchanged patients
Assumes
2 nd Berg 45
◦
MDC
90 = SEM x √2 x 1.65 Beyond the threshold of measurement error is
the threshold for important change
MDC of BBS in people with Chronic Stroke: Commonly known as MCID
90
Flansbjer 2012
◦ SEM = 1.40
MDC = 3.27
◦
90
- Hiengkaew 2012
◦ SEM = 1.73 ◦ MDC = 4.04
90 Distribution-based methods
- o
Definition: “the smallest difference in score
in the domain of interest which patient Effect size
o
perceive as beneficial and which would ES= M1-M2 mandate, in the absence of troublesome SD
baseline
side effects and excessive cost, a change in
o Standardized response mean
Jaeschke, et al, Control Clin patient’s management” o
Trials1989;10:407-15 SRM = M1-M2 OR
SD diff
“The smallest difference in a score that is (Hayes and considered worthwhile or important” Woolley, Pharmacoeconomics 2000;18:419-23)
7: A very great deal better
15 Point Global 6: A great deal better
Rating of 5: A good deal better
ID 4: Moderately better C
Change Scale
Important? Who says so?
‣ M
3: Somewhat better (GROC) ( Jaeschke,1989)
Anchor-based methods
‣ 2: A little better
ID
External anchor used to define C
1: About the same, hardly any better at all ‣
M
clinical importance 0: No change
O o
Achievement of goal, discharge home N
−1: About the same, hardly any worse at all
etc
−2: A little worse o
Direct survey
−3: Somewhat worse o
Global Rating of Change Scale (GROC) −4: Moderately worse often used
−5: A good deal worse −6: A great deal worse −7: A very great deal worse
People categorized as having achieved MCID or No MCID
MCID of FIM
Identify change score on outcome measure
n = 113
that best categorizes people as achieving
Used GROC +3 as MCID or No MCID
MCID indicator
Apply diagnostic Test Methods
Cutoff score from
◦ Sensitivity
ROC curve = 22
◦ Specificity AUC = .85
◦ Positive and Negative Predictive Values ◦ Likelihood ratios Derived from Beninato et al., Arch Phys Med Rehabil. 2006;87:32-9
MCID based on MCID based on the GROC the GROC
<3 ≥3
<3 ≥3 a b
≥ Positive Predictive Value a+b
Positive Predictive Value
score TP FP
77
3
80 Change FIM ≥22
a/a+b 77/80 = .96
Score Change
< c d
Negative Predictive Value
c+d
Negative Predictive Value
Score <22
23
10
33 score FN TN
d/c+d 10/33 = .30
a+c b+d a+b+c+d 100 13 113
Sensitivity (SN) a/a+c Sensitivity (SN) 77/100 = .77
Specificity (SP) d/b+d Specificity (SP) 10/13 = .77
Likelihood ratios
- +LR = SN/1-SP = .77/.33 = 2.33
- +LR = SN/1-SP
- -LR = 1-SN/SP = .33/.77 = .43
- -LR = 1-SN/SP
The SEM is a estimate of error that takes into
If my patient achieves a change score greater
account variability in a stable group of patients
than the MCID, then that change reflects
The MDC and MCID are useful and informative
important change
threshold values for interpreting patient change Need to be aware of the anchor that was used scores
Important? Who says so? MDC is an indication of achieving real change
Does my patient share characteristics with the
(beyond measurement error)
study sample
MCID tells us that important change has taken place Use of diagnostic test statistics tell us how
accurate these estimates are.
30 Items across 3 domains
◦ 3: independent, grossly normal pattern without assistive device
C: full movement withmarked deviation ◦ 2: able to complete movement comparable to unaffected side
Mobility (Activity) ◦ 0: unable to perform ◦ 1:
A: requires partial assistance with deviation
B: requires partial assistance grossly normal
◦ 2: independent, grossly normal pattern with assistive device
How do I interpret the score, what are norms for this time frame/time in the continuum of care?
A: part of movement marked deviation
How much change necessary to be reasonably confident that my patient really changed?
Important change?
Predictive ability?
Mean (SD) STREAM Total 75 (26.7) LE subscale 73 (33.3) UE subscale 75 (28.9) Mobility subscale 74 (25.9) Gait speed (m/s) 0.55 (0.38)
Our patient: Total: 70 UE subscale: 68 LE subscale: 70 Mobility: 69
Ahmed et al. Phys Ther. 2003; 83:617-630.
B: part of movement comparable to unaffected
1:
66 y/o male: JR
Acute care hospital
In patient rehabilitation hospital
Out patient rehabilitation center
Chronic
Stroke Rehabilitation Assessment of Movement (STREAM)
0: unable to perform ◦
◦ Our patient’s score
Total: 70
UE subscale: 68 LE subscale: 70
Mobility: 69
UE and LE: (Body Structure/Function) ◦
C: Independently but abnormal movement pattern
MCID?
Our patient: Total:
Hsueh et al.
70 MDC
◦ UE subscale: 14 UE subscale: 68
◦ LE subscale: 12.6 Need to increase to
◦ ◦
82
LE subscale: 70
Need to increase to ◦
83
Mobility: 69
Hsueh et al. Neurorehabil Neural Repair. 2008; 22:737-744.
63 individuals a 8 days post stroke mean of 8 (SD=3) Average LOS: 18 days post stroke days
Initial scores of
JR’s: Outcome
subjects <63 Measures
JR: initial total Berg Balance Scale ◦
30/56
STREAM: 70
Fugl Meyer ◦
~20% probability he
UE: 35/66 will be discharged
LE: 18/34 home.
Ahmed et al. PHYS THER.
Dobrez D, et al. Am J Phys 2003; 83:617-630.
Med Rehabil. 2010;89:198-204 How do I interpret the score, what are Days post BBS Score N
Stroke norms for this time frame/time in the
Mao et al. 14 days post 22.3 (22.2) 123 continuum of care?
Stroke.2002; stroke
How much change necessary to be 33:1022- reasonably confident that my patient
1027 really changed?
9.2 (6.8) 19.6 (16.6)
55 O’Dell et al. P M&R. days post Range: 0-
Important change?
2013;5:392- stroke
54
Predictive ability? 399
Our patient: 30/56
31
Time post stroke N Baseline score
MDC
Sanford et al 56 days
12
95
=10.0
95
=8.9 Wagner et al
14 months
13
35 UE: MDC
95
: 5.2 See et al
54 months
31 UE: MDC
Stevensen et al
90
: 3.2 Sanford et al. Phys Ther. 1993;73:447-454.
Wagner et al. Phys Ther. 2008;88:652-663. See et al. Neurorehabil Neural Rep. 2013.
Our Patient: UE: 35/66 LE: 18/34
Time post stroke MCID Anchor Accuracy Shelton et al 2001
17 days 10 point =1.5 D/C FIM self care 10 point=1.9 point D/C FIM mobility
FIM Self Care FIM Mobility Page et al 2012 UE motor 60 months MCID: 4.25-7.5
Therapists’ perception of different UE movements/fu nction AUC: 0.61-0.70
Sens: 0.53-
0.64 Spec: 0.61-
0.83 Arya et al 2011 UE motor 8.5 weeks MCID: 9-10 Patient GROC mRankin AUC: 0.84-0.98
Sens: 0.80-
0.97 Spec: 0.70-
0.89
Duncan et al. Stroke. 1992;23:1084-1089.
Our patient: UE: 35/66 LE: 18/34 Total=53
◦ Mild: >80
◦ Moderate: 56-79
◦ 30.3 (23.3) days post stroke ◦ All subjects: 43.0 ◦ Assist: 35.5
MDC
90
: 5.8
◦ Independent: 5.3, Standby: 5.0, Assist: 6.8
MDC
95
: 6.9
◦ Independent: 6.3, Standby: 6.0, Assist: 8.1
Stevensen et al. Aust J Physiother. 2001;47:29-38.
Our Patient: 30/56 Need to improve >=39 to be 95% confident a real change occurred.
MCID?
Wee et al
◦ 313 subjects
◦ Mod severe: 36-55
◦ Severe: 0-35
Stratified
stroke
57.1 (33.4) Within 24 hours of
◦ Initial total motor:
◦ 105 subjects
Duncan et al
Wee et al. Arch Phys Med Rehabil. 2003;84:731-735. Our patient: admission score: 30 ~65% D/C home Family support: ~95% D/C home
◦ Admit BBS: 21
◦ 37 (22) days post stroke
FM MCID: JR: UE: 35/66, LE: 18/34
41 UE: MDC
LE: MDC
- 0.10 to 0.12 m/s Flansbjer et al 2005 16 months 0.89 m/s 1
Our patient: 0.56 m/s Fulk et al. J Neurol Phys Ther. 2011;35:82-89.
Time post stroke Mean GS MDC Stephenson et al 1999
112 days 0.80 m/s 95% CI of change:
st session 0.94 m/s 2 nd session Smallest Real
Difference: -0.15 to 0.25 m/s Fulk et al 2008 35 days post stroke 0.45 m/s 1 st session 0.54 m/s 2 nd session MDC
90 : All: 0.30 m/s
Assistance: 0.07 m/s Used AD: 0.18 m/s
Stephens et al. Clin Rehabil. 1999;13:171-181 Flansbjer et al. J Rehabil Med. 2005;37:75-82. Fulk et al. J Neurol Phys Ther. 2008;32:8-13.
Our patient: 0.56 m/s Important Change in Gait Speed?
Time post stroke Initial Gait Speed MCID Anchor Accuracy Fulk et al 2011
56 to 139 days post stroke 0.56 (0.22) m/s
0.17 m/s 0.19 m/s Patient GROC Therapist GROC Patient:
AUC: 0.80 Sens/Spec: 0.73/0.73 Therapist: AUC: 0.58 Sens/Spec: 0.62/0.50 Tilson et al 2010 20 to 60 days post stroke
0.18 (0.16) m/s 0.16 m/s 1 point improvement on the mRankin
AUC: 0.69 Sens/Spec: 0.74/0.57
Tilson et al. Phys Ther. 2010:90.
Bohannon 1997 Tilson et al. Phys Ther. 2010 90:196 –208.
5 point likert scale ◦
1 could not do it at all ◦
2 very difficult ◦
3 somewhat difficult ◦
4 a little difficult ◦
5 not difficult at all SIS-16 Stroke Impact
Scale-8 domains
◦ Strength
◦ Hand Function
◦ Mobility
◦ ADLs
◦ Emotion
◦ Memory
◦ Communication
Our patient: 0.56 m/s How much change in gait speed needs to occur to be confident that it is real?
Mean: 0.39 (0.22) m/s
3 months post stroke
◦
◦ Subacute stage of
recovery
Gait Speed ◦ 0.56 m/s
Stroke Impact Scale (SIS)
◦
65: total
◦ Strength: 65 ◦
Hand Function: 54
◦
Mobility: 68
◦
ADLs: 68
◦
Emotion: 68
Memory: 75
post stroke
Important change? Normative data with healthy individuals (M/F):
Tilson et al ◦ 283 subjects, 60 days
◦ 60s: 1.36 / 1.30 ◦ 70s: 1.33 / 1.27
50s: 1.39 / 1.40
◦
40s: 1.46 / 1.39
◦ 20s: 1.39 / 1.41 ◦ 30s: 1.46 / 1.42 ◦
How much change necessary to be reasonably confident that my patient really changed?
◦
How do I interpret the score, what are norms for this time frame/time in the continuum of care?
SIS 16: 62
◦
Social Participation: 52
◦
Communication: 45
◦ Social Participation
Duncan et al Huang et al 18 Our Patient 90-120 days months post post stokre stroke
Total 65
Our Patient
Chronic, 17.7 Strength 61.9 (22.0) 40.73 (20.0)
65 Strength: 65 ◦
months post stroke
Memory 77.8 (19.1) 81.5 (19.2)
75 ADLs: 68 ◦
Strength = 24.0 ◦
Emotion 74.3 (18.1) 59.6 (17.2)
68 Mobility: 68 ◦
ADL/IADL = 17.3 ◦
Communication 81.0 (19.1) 89.7 (16.9)
45 Hand Function: 54 ◦
Mobility = 15.1 ◦
ADL 66.5 (23.2) 67.4 (20.1)
68 Hand function = 25.9 Mobility 60.2 (23.1) 79.2 (18.1) 68 ◦ Hand Function 55.9 (34.5) 29.6 (25.4)
54 Social 58.9 (25.7) 47.9 (25.1)
52 SIS-16 67.5 (21.2) 62.0 (12.3)
62 Duncan et al. Stroke. 2002;33:2593- 2599.
Lin et al. Neurorehabil Neural Rep. Huang et al. Neurorehabil Neural 2010;24:486-492.
Repair.2010;24:559-566 MDC MDC MCID Acute/ MCID Acute/ Chronic Subacute Chronic Subacute
STREAM Time post MCID Anchor Accuracy
Total stroke
STREAM
14 Fulk et al 2 months
9.4 Patient GROC Patient: AUC:
UE
SIS-16
14.1 Therapist GROC
0.72 STREAM
13 Sens/Spec: LE
0.81/0.63
STREAM
Therapist:
Mobility
AUC: 0.65
Berg
7 Sens/Spec:
0.76/0.57 F-M total Lin et al 17.5 Strength: 9.2 Mean score of N/A F-M UE
10 3-5 9-10 5-8
months ADL: 5.9 subjects that
F-M LE
9 Mobility: 4.5 reported 10-15% Gait 0.30 m/s 0.25 m/s 0.16 to 0.17
Hand: 17.8 on overall
Speed 0.12 m/s
change
SIS-16
10 Fulk et al. Top Stroke Rehabil. 2010;17:477-483.
Lin et al. Neurorehabil Neural Rep. 2010. 24:486-492
MCID depends on Anchor used
What if there is no value for MDC or MCID for
Motor FIM using GROC ratings MCID = 17 ◦
my patient?
points (Beninato et al 2006)
Cautiously interpret the values available
◦ Motor FIM using change in mRS = 11 points
◦ (Wallace et al 2002)
SEM and MDC depend on reliability
◦ Only scores are reliable, not outcome instruments Anchor should be closely related to construct
◦ Reliability is not transferable being measuredMDC derived from research studies with strict Gait Speed by GROC survey
◦
.175 m/sec SN .81, SP .81(Fulk et al 2012)
methodology
◦ Gait speed by change in mRS ◦ Establish for your own practice group
.16 m/sec SN .74 SP .57 (Tilson et al) Riddle and Stratford. Is This Change Real, 2013, F.A Davis
Beninato et al . Arch Phys Med Rehabil. 2006;87:32-9 Revicki D, et al.. J Clin Epidemiol. 2008; 61:102-109
Wallace et al. J Clin Epidemiol. 2002;55:922-928 Wells G, et al. J Rheumatol. 2001; 28:406-412
Tilson et al. Phys Ther. 2010; 90(2):196-208 Fulk et al JNPT 2011; 35:82-89
Baseline scores Use of Diagnostic Test Methods to determine
◦ Lower baseline requires more change to achieve MDC
MCID
◦ Additional information on accuracy of estimates
Example (Beninato et al 2006)
◦ ◦ Little research available on this
Admission FIM scores10-40 required 27 point change Gold Standard of
Admission FIM scores 41-60 required 23 point change Change
Yes No
Whether considering improvement versus
a b ≥ a+b
decline
score TP FP Change Score
< c d c+d score FN TN
Beninato et al . Arch Phys Med Rehabil. 2006;87:32-9 a+c b+d a+b+c+d
Wang et al. Phys Ther. 2011; 91:675-688 Beninato M, Portney LG, JNPT, 2011;35:75-81 Riddle and Stratford. Is This Change Real, 2013, F.A Davis
MCID estimates needed for more outcome
Stroke Edge Resources
measures
◦ ◦ Only 6 of 24 recommended by EDGE task force
have established MCID scores
MCID estimates for OMs at different
stages of recovery
◦
severity levels
◦
Internet Stroke Center settings
◦
◦
different anchors
◦
MCID using different anchors
◦ Any one value of MCID is an estimate ◦ Need to consider different perspectives